1. Home
  2. NPCE

NPCE

Neuropace Inc.

Logo Neuropace Inc.

Health Care

Medical Specialities

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.

Founded: 1997 Country:
United States
United States
Employees: N/A City: MOUNTAIN VIEW
Market Cap: 410.4M IPO Year: 2021
Target Price: $17.00 AVG Volume (30 days): 103.9K
Analyst Decision: Buy Number of Analysts: 6
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.27 EPS Growth: N/A
52 Week Low/High: $3.80 - $18.15 Next Earning Date: 05-02-2024
Revenue: $65,421,000 Revenue Growth: 43.72%
Revenue Growth (this year): 17.25% Revenue Growth (next year): 17.54%

Share on Social Networks: